Accelr8 Technology Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Accelr8 Technology Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Accelr8 Technology Corporation. The Company's principal activity is to develop and commercialize innovative, integrated system for rapid identification of bacteria and their antibiotic resistance in critically ill patients. The major products include BACcelr8r(tm), OptiChem(r), OptArray(TM). BACcelr8r(tm) intended to be used in clinical diagnostics for life-threatening bacterial infections. OptiChem(r) is into surface coatings and assay processing methods. OptArray(TM) produces micro arraying slides and also develops OptiPlate(TM) arrayable microtiter plates. The Company is granted license to Schott Jenaer Glas GmbH (SCHOTT), for manufacturing and marketing OptiChem microarraying products. The major trade marks include BACcelr8r, OptArray(TM),OptiChem(R), OptiPlate(TM),QuanDx(TM),YoDx(TM) and Quantum Microbiology(TM). The Company's office and laboratory is situated in Colorado.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report